Transforming growth factor-β1 (TGF-β1) is considered key contributor to the progression of breast cancer [3, 4]; TGF-β1 signaling features a growth inhibitory effect at an early stage of breast cancer cells, but aggressive oncogenic activity at the advanced malignant state [5–7]. Here, TGFB1 is linked to breast cancer.